HIMS
Overvalued by 134.4% based on the discounted cash flow analysis.
Market cap | $5.82 Billion |
---|---|
Enterprise Value | $5.69 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $0.58 |
Beta | 1.66 |
Outstanding Shares | 219,027,485 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 47.32 |
---|---|
PEG | -4.31 |
Price to Sales | 5.07 |
Price to Book Ratio | 12.68 |
Enterprise Value to Revenue | 4.58 |
Enterprise Value to EBIT | 184.49 |
Enterprise Value to Net Income | 56 |
Total Debt to Enterprise | 0.02 |
Debt to Equity | 0.18 |
No data
No data
Hims & Hers is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermato...